Authorea (Authorea),
Journal Year:
2023,
Volume and Issue:
unknown
Published: June 8, 2023
Ferroptosis
is
a
new
non-apoptotic
form
of
regulatory
cell
death,
which
characterized
by
intracellular
iron
overload
and
excessive
accumulation
lipid
peroxides
reactive
oxygen
species
(ROS).
closely
related
to
iron,
amino
acid,
metabolism
disorders.
increasingly
recognized
as
an
important
process
mediating
the
pathogenesis
progression
acute
ischemic
stroke,
it
can
be
involved
in
influencing
stroke
risk
factors
atherosclerosis,
atrial
fibrillation,
hypertension,
diabetes
mellitus,
obstructive
sleep
apnea.
Therefore,
understanding
mechanisms
ferroptosis
regulation
different
diseases
may
have
significant
implications
for
preventive
treatment
improvement
prognosis
patients
with
stroke.
This
article
reviews
not
only
specific
development
but
also
relevant
associations
between
ferroptosis,
describes
current
limitations
future
directions
its
factors.
Redox Biology,
Journal Year:
2023,
Volume and Issue:
67, P. 102923 - 102923
Published: Oct. 6, 2023
As
the
predominant
immunosuppressive
component
within
tumor
microenvironment
(TME),
cancer-associated
fibroblasts
(CAFs)
inhibit
Natural
Killer
cell
(NK
cell)
activity
to
promote
progression
and
immune
escape;
however,
mechanisms
of
cross-talk
between
CAFs
NK
cells
in
gastric
cancer
(GC)
remain
poorly
understood.
In
this
study,
we
demonstrate
that
levels
are
inversely
correlated
with
abundance
human
GC.
impair
anti-tumor
capacity
by
inducing
ferroptosis,
a
death
process
characterized
accumulation
iron-dependent
lipid
peroxides.
induce
ferroptosis
promoting
iron
overload;
conversely,
decreased
intracellular
protect
against
CAF-induced
ferroptosis.
Mechanistically,
increase
labile
pool
via
export
into
TME,
which
is
mediated
upregulated
expression
regulatory
genes
ferroportin1
hephaestin
CAFs.
Moreover,
CAF-derived
follistatin
like
protein
1(FSTL1)
upregulates
NCOA4
DIP2A-P38
pathway,
NCOA4-mediated
ferritinophagy
required
for
patient-derived
organoid
model,
functional
targeting
using
combination
deferoxamine
FSTL1-neutralizing
antibody
significantly
alleviate
boost
cytotoxicity
This
study
demonstrates
novel
mechanism
suppression
TME
presents
potential
therapeutic
approach
augment
response
GC
cells.
Biomedicine & Pharmacotherapy,
Journal Year:
2024,
Volume and Issue:
171, P. 116112 - 116112
Published: Jan. 2, 2024
Ferroptosis
is
a
newly
identified
form
of
non-apoptotic
programmed
cell
death,
characterized
by
the
iron-dependent
accumulation
lethal
lipid
reactive
oxygen
species
(ROS)
and
peroxidation
membrane
polyunsaturated
fatty
acid
phospholipids
(PUFA-PLs).
unique
among
other
death
modalities
in
many
aspects.
It
initiated
excessive
oxidative
damage
due
to
iron
overload
compromised
antioxidant
defense
systems,
including
system
Xc-/
glutathione
(GSH)/glutathione
peroxidase
4
(GPX4)
pathway
GPX4-independent
pathways.
In
past
ten
years,
ferroptosis
was
reported
play
critical
role
pathogenesis
various
cardiovascular
diseases,
e.g.,
atherosclerosis
(AS),
arrhythmia,
heart
failure,
diabetic
cardiomyopathy,
myocardial
ischemia-reperfusion
injury.
Studies
have
dysfunctional
metabolism
abnormal
expression
profiles
ferroptosis-related
factors,
iron,
GSH,
GPX4,
ferroportin
(FPN),
SLC7A11
(xCT),
as
indicators
for
atherogenesis.
Moreover,
plaque
cells,
i.e.,
vascular
endothelial
(VEC),
macrophage,
smooth
muscle
(VSMC),
positively
correlate
with
atherosclerotic
development.
Many
macromolecules,
drugs,
Chinese
herbs,
food
extracts
can
inhibit
atherogenic
process
suppressing
cells.
contrast,
some
inducers
significant
pro-atherogenic
effects.
However,
mechanisms
through
which
affects
progression
AS
still
need
be
well-known.
This
review
summarizes
molecular
their
emerging
AS,
aimed
at
providing
novel,
promising
druggable
targets
anti-AS
therapy.
Journal of Lipid and Atherosclerosis,
Journal Year:
2025,
Volume and Issue:
14(1), P. 30 - 30
Published: Jan. 1, 2025
While
advances
in
cancer
treatment
have
led
to
improved
survival
rates,
survivors
are
at
a
significant
risk
of
developing
atherosclerotic
cardiovascular
disease
(ASCVD).
This
review
examines
the
risk,
diagnosis,
and
prevention
ASCVD
this
population.
Cancer
survivors,
especially
those
diagnosed
with
certain
types,
face
significantly
higher
than
general
We
introduce
"triad
model"
explain
increased
among
patients.
model
includes
three
interconnected
components:
common
catalysts,
influence,
impact.
The
factors
contributing
shared
between
ASCVD,
such
as
smoking,
obesity,
systemic
inflammation;
direct
effects
on
health
through
chronic
inflammation
endothelial
damage;
anticancer
treatments,
including
chemotherapy
radiation,
which
can
worsen
complications
hasten
progression
ASCVD.
Furthermore,
dying
from
highlighting
necessity
for
tailored
guidelines
strategies
management
explores
utility
diagnostic
tools,
coronary
artery
calcium
scoring,
predicting
managing
risk.
It
also
emphasizes
importance
that
include
regular
monitoring
lifestyle
modifications.
Finally,
relationship
highlights
integrated
comprehensive
care
approaches.
Continued
research,
development
prediction
models,
specific
preventative
essential
improve
survivors'
overall
outcomes.
Acta Biochimica et Biophysica Sinica,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Jan. 26, 2024
Atherosclerosis
(AS),
the
main
contributor
to
acute
cardiovascular
events,
such
as
myocardial
infarction
and
ischemic
stroke,
is
characterized
by
necrotic
core
formation
plaque
instability
induced
cell
death.
The
mechanisms
of
death
in
AS
have
recently
been
identified
elucidated.
Ferroptosis,
a
novel
iron-dependent
form
death,
has
proven
participate
atherosclerotic
progression
increasing
endothelial
reactive
oxygen
species
(ROS)
levels
lipid
peroxidation.
Furthermore,
accumulated
intracellular
iron
activates
various
signaling
pathways
or
risk
factors
for
AS,
abnormal
metabolism,
oxidative
stress,
inflammation,
which
can
eventually
lead
disordered
function
macrophages,
vascular
smooth
muscle
cells,
cells.
However,
molecular
through
ferroptosis
affects
development
are
not
entirely
understood.
This
review
systematically
summarizes
interactions
between
provides
feasible
approach
inhibiting
from
perspective
ferroptosis.
Cell Death Discovery,
Journal Year:
2025,
Volume and Issue:
11(1)
Published: Jan. 24, 2025
Abstract
Environmental
pollution
represents
a
significant
public
health
concern,
with
the
potential
risks
associated
environmental
pollutants
receiving
considerable
attention
over
an
extended
period.
In
recent
years,
substantial
body
of
research
has
been
dedicated
to
this
topic.
Since
discovery
ferroptosis,
iron-dependent
programmed
cell
death
typically
characterized
by
lipid
peroxidation,
in
2012,
there
have
advances
study
its
role
and
mechanism
various
diseases.
A
growing
number
studies
also
demonstrated
involvement
ferroptosis
damage
caused
organism
pollutants,
molecular
mechanisms
involved
partially
elucidated.
The
targeting
be
effective
means
ameliorating
PM2.5,
organic
inorganic
ionizing
radiation.
This
review
begins
providing
summary
most
important
ferroptosis.
It
then
proceeds
offer
critical
analysis
effects
induced
pollutants.
Furthermore,
as
is
case
all
rapidly
evolving
areas,
are
numerous
unanswered
questions
challenges
pertaining
pollutant-induced
which
we
discuss
attempt
provide
some
directions
clues
for
future
field.
Biomedicine & Pharmacotherapy,
Journal Year:
2024,
Volume and Issue:
173, P. 116356 - 116356
Published: Feb. 29, 2024
Aging,
an
inevitable
aspect
of
human
existence,
serves
as
one
the
predominant
risk
factors
for
vascular
diseases.
Delving
into
mystery
disease's
pathophysiology,
profound
involvement
programmed
cell
death
(PCD)
has
been
extensively
demonstrated.
PCD
is
a
fundamental
biological
process
that
plays
crucial
role
in
both
normal
physiology
and
pathology,
including
recently
discovered
form,
ferroptosis.
Ferroptosis
characterized
by
its
reliance
on
iron
lipid
peroxidation,
significant
disease
pathophysiology
increasingly
acknowledged.
This
phenomenon
not
only
offers
promising
therapeutic
target
but
also
deepens
our
understanding
complex
relationship
between
ferroptosis
age-related
Consequently,
this
article
aims
to
thoroughly
review
mechanisms
enable
effective
control
inhibition
It
focuses
genetic
pharmacological
interventions,
with
goal
developing
innovative
strategies
combat
Biomedicine & Pharmacotherapy,
Journal Year:
2024,
Volume and Issue:
179, P. 117323 - 117323
Published: Aug. 28, 2024
Recently,
increased
attention
has
been
focused
on
the
regulatory
mechanism
and
potential
clinical
application
of
ferroptosis
in
cancer
cells,
especially
therapy-related
ferroptosis.
However,
treatment-related
prospects
strategies
for
future
treatment
still
require
further
clarification.
This
review
highlights
molecular
relationships
between
different
antitumour
drugs,
including
commonly
used
chemotherapy
radiation
therapy
vitamins,
also
proposes
treatments
that
involve
ferroptosis,
with
an
aim
to
develop
a
new
strategy
transformative
emerging
field
improve
therapy.
PLoS ONE,
Journal Year:
2025,
Volume and Issue:
20(1), P. e0314861 - e0314861
Published: Jan. 30, 2025
Radiotherapy
is
the
main
treatment
for
patients
with
head
and
neck
cancer
(HNC)
associated
an
increased
risk
of
ischemic
cerebrovascular
events
(ICVE).
The
purpose
this
cross-sectional
study
was
to
determine
incidence
ICVE
carotid
artery
stenosis
(CAS)
in
HNC
who
receive
radiotherapy
factors
CAS.
We
enrolled
907
underwent
between
February
2011
June
2022
obtained
information
on
their
clinical
tumor
characteristics
from
records.
Data
atherosclerosis,
medications
used,
were
also
collected.
followed
through
end
2023
unless
they
died
or
lost
follow-up.
overall
1.98%,
a
cumulative
1.65%
over
5
years.
In
did
not
have
preexisting
lesion,
significant
CAS
1.3%
at
12
months,
2.2%
24
2.5%
36
months
post-radiotherapy.
most
important
new
age
>65
years
(aHR
=
2.60,
p
0.008,
95%
confidence
Interval:
1.28–5.30),
laryngeal
2.36,
p<0.017,
1.01–5.55),
total
plaque
score
1.38,
p<0.001,
1.23–1.56).
There
increase
stenosis,
score,
wall
thickness
all
areas
(p<0.001).
found
be
lower
Thai
population
than
other
populations.
years,
cancer,
score.
Changes
detected
early
affected
artery.
Patients
treated
by
should
assessed
undergo
vascular
surveillance
during